Losartan
-
Losartan
structure -
-
CAS No:
114798-26-4
-
Formula:
C22H23ClN6O
-
Chemical Name:
Losartan
-
Synonyms:
1H-Imidazole-5-methanol,2-butyl-4-chloro-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-;1H-Imidazole-5-methanol,2-butyl-4-chloro-1-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-;2-Butyl-4-chloro-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol;DUP 89;Losartan;Lortaan;2-Butyl-4-chloro-1-[[2′-(1H-tetrazol-5-yl)-1,1′-biphenyl-4-yl]methyl]-1H-imidazole-5-methanol;Angizaar;Allisartan;1-[1-[[2′-(2H-Tetrazol-5-yl)biphenyl-4-yl]methyl]-2-butyl-4-chloro-1H-imidazol-5-yl]methanol;Lozap;Xartan;[2-Butyl-5-chloro-3-[2′-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-imidazol-4-yl]-methanol;[2-Butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol;[2-Butyl-4-chloro-1-([4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl)-1H-imidazol-5-yl]methanol
-
Categories:
Active Pharmaceutical Ingredients > Circulatory System Drugs
-
CAS No:
Description
ChEBI: A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-positionLosartan, 2-butyl-4-chloro-1-[p-(o-1H-tetrazol-5-yl-phenyl)benzyl]imidazole-5-methanol monopotassiumsalt (Cozarr), was the first nonpeptide imidazole to beintroduced as an orally active angiotensin II antagonist withhigh specificity for AT1. When administered to patients, itundergoes extensive first-pass metabolism, with the 5-me
Characteristics
92.5
4.3
Solid
1.35±0.1 g/cm3(Predicted)
184 °C
682.0±65.0 °C(Predicted)
366.3±34.3 °C
1.681
4.70e-03 g/L
Conditions for safe storage, including any incompatibilities: Keep container tightly closed in a dry and well-ventilated place. Store under inert gas. Moisture sensitive.
5.44X10-18 mm Hg at 25 deg C (est)
5.5None
Safety Information
III
4.3
3278
3
36/37/38
26-36
Xi
Stable under recommended storage conditions.
P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, P501
H315
Losartan Use and Manufacturing
A solution of losartan (0.42 g) in a mixture of tetrahydrofuran (3 ml) and chlorobenzene (6 ml) is stirred thoroughly with an aqueous solution of hydriodic acid (0.1 molar, 10.5 ml) with gentle warming. The aqueous phase is separated and transferred to a rotary evaporator flask. High vacuum is applied and the flask is maintained at an external temperature of about 40C and rotated rapidly to remove the majority of the solvent as quickly as possible. The flask and amorphous product is then placed in a desiccator containing a dish of phosphoric oxide drying agent, and dried under high vacuum to a residual solvent level of below 0.2%. Yield 0.55 g. X-ray powder diffraction shows a single very broad diffraction peak typical of non-crystalline material. (50 mg, 118 mumol), chloroacetic acid (13.4 mg, 142 mumol) and dimethylaminopyridine (2.8 mg, 27 mumol) were dissolved in THF (4 ml) and cooled to 0 C. Diisopropylcarbodiimide (23 mul, 142 mumol) was added and stirring continued at 0 C. for 90 mins, after which the mixture was allowed to warm to room temperature. The reaction was monitored by thin layer chromatography (5% of (10% NH4OH in MeOH) in DCM). After overnight stirring, the reaction was deemed complete and the mixture was diluted with DCM (10 ml) and washed with 0.1 M HCl (15 ml) and brine (15 ml). The organic portion was dried over Na2SO4 and solvents removed in vacuo. Further drying under vacuum gave chloroacetyl
antihypertensive;antagonist of angiotensin type 1
Computed Properties
Molecular Weight:422.9
XLogP3:4.3
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:5
Rotatable Bond Count:8
Exact Mass:422.1621871
Monoisotopic Mass:422.1621871
Topological Polar Surface Area:92.5
Heavy Atom Count:30
Complexity:520
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Drug Function and Efficacy
Blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin II by selectively blocking the binding of angiotensin II to the AT1 receptor, leading to vasodilation and reduced blood pressure.
Registered Holders
-
ATUL BIOSCIENCE LTD
Active
United States
-
DR. REDDY'S LABORATORIES LIMITED
Active
European Union
-
HETERO LABS LIMITED
Active
European Union
Recommended Suppliers of Losartan
-
CN
5 YRS
Business licensed Certified factoryManufactory Supplier of D-Biotin,Tobramycin base,L(-)-Carnitine base,Polymyxin B sulfate USP,Kanamycin sulfate monohydrate,Finasteride 99% USP -
CN
3 YRS
Business licensedTrader Supplier of Estradiol,Progesterone,GS441524,4-Butylresorcinol,DeoxyArbutin,Coenzyme Q10,Piracetam,Pregabalin,Ketoprofen,omeprazole,Fullerene C60,Melatonin,Nicotinamide riboside chloride,lactoferrin,Tylosin tartrate,Gentamycin Sulfate,Levamisole HCl,Praziquantel,Ivermectin,GA3,Pepsin,MT2,5 amino 1MQ,selank,semaxInquiryCAS No.: 114798-26-4Grade: Pharmaceutical GradeContent: 99% -
CN
3 YRS
Business licensedTrader Supplier of CHEMICALS,REAGENTSInquiryCAS No.: 114798-26-4Grade: Pharmaceutical GradeContent: 99% -
CN
3 YRS
Business licensedTrader Supplier of chemical
Learn More Other Chemicals
-
5-Deshydroxy-5-formyl N,N’-Ditrityl Losartan α-Butyl-losartan Aldehyde Adduct
1246817-19-5
-
Losartan potassium
124750-99-8
-
Losartan carboxylic acid
124750-92-1
-
Deshydroxymethyl Losartan Trifluoroacetate Salt Formula
1215727-33-5
-
Dronedarone Formula
141626-36-0
-
Zofenopril calcium Formula
81938-43-4
-
3-Bromo-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one Structure
86499-96-9
-
Tirofiban hydrochloride monohydrate Structure
150915-40-5
-
What is Saxagliptin
361442-04-8
-
What is Dapoxetine
119356-77-3